F31
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Diagnosis of Bipolar Disorder I or II according to DSM-5 Currently experiencing a euthymic interval or mild to moderate depressive symptoms for at least two weeks, as defined by clinical cut-off values in QIDS-C, QIDS-SR, YMRS, ASRM Written informed consent
Exclusion criteria
Exclusion criteria: Current severe affective episode or (hypo)manic episode Acute suicidality Schizoaffective or schizophrenic disorder Significant substance dependence within the past six months, excluding caffeine and nicotine Antisocial personality disorder Organic mental disorders Lack of consent to participate in the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Feasibility was assessed by the dropout rate, the attendance rate and satisfaction rating after the intervention (T1). The participants who did not fill out the questionnaires after the end of the 8-week training period (T1), were classified as drop-out. Attendance was indicated by the number of attended session, with a minimum of one and a maximum of eight attended sessions. Satisfaction was assessed using the “Fragebogen zur Messung von Patientenzufriedenheit” (ZUF-8; Schmidt & Nübling, 2002), the German version of the Client Satisfaction Questionaire (CSQ-8; Attkisson & Zweck, 1982) and adapted to the context. Items are scored on a Likert scale from 1 (low satisfaction) to 4 (high satisfaction). | — |
Secondary
| Measure | Time frame |
|---|---|
| Preliminary effects of the training were assessed by measuring manic and depressive symptoms before (T0), after each session (T0.1 - T0.8) , one week after the last session (T1) and six months after (T2). Mania was assessed by the Altman Self Rating Mania Scale (ASRM; Altman et al., 1997) and Depression by the Quick Inventory of Depressive Symptoms (QIDS-SR; Rush et al., 2003). Further changes in the following variables were assessed at T0, T1 and T2: - Psychosocial Functioning measured by MINI-ICF (Linden & Baron, 2005). - Metacognitions measured by subscales of the Metacognitions Questionnaire (MCQ-30; Wells & Cartwright-Hatton, 2004): “Positive Beliefs about Worry”, “Negative Beliefs ”, “Cognitive Consciousness” - Dysfunctional Attitudes measured by the Dysfunctional Attitudes Scale (DAS-A and B; Weissman, 1979). - Mindfulness measured by a short version of the Freiburger Fragenbogen zur Achtsamkeit (FFA; Buchheld & Walach, 2001). - Life Quality measured by the WHO-QOL-BREF (WHOQOL-Group, 1998) Potential confounding variables were assessed at T0. Those were demographic variables, expectations towards the training as well as patients’ cognitive function, which were measured by the Trail Making Test A and B (TMT A and B; Leiter & Partington, 1949), Zahlen-Symbol-Test (ZST; Aster et al., 2006) and the Wortschatztest (WST; Lehrl et al., 1971). | — |
Countries
Germany
Contacts
Charité – Universitätsmedizin Berlin, Klinik für Psychiatrie und Psychotherapie